<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03404518</url>
  </required_header>
  <id_info>
    <org_study_id>010218</org_study_id>
    <nct_id>NCT03404518</nct_id>
  </id_info>
  <brief_title>Patient Narcotic Requirements After Outpatient Otolaryngology Procedures</brief_title>
  <official_title>Quantifying Narcotic Use in Outpatient Otolaryngology Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient's pain level and narcotic requirements will be evaluated after routine outpatient
      Otolaryngology procedures. This will be done by having study participants record their pain
      level and medication usage from home.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is routine practice to give narcotic medication after surgery for pain control however the
      abuse of prescription medications has become the fastest growing drug problem in the United
      States. Research has shown that post operative pain for some common Ear, Nose, and Throat
      (ENT) procedures are not severe but there is limited data looking at patient narcotic needs
      and their usage pattern to help inform physicians on how much to prescribe.

      The objective of this study is to evaluate patient pain level in the immediate post-operative
      period and quantify pain medication usage in patients who undergo outpatient ENT surgeries.

      Patients who undergo the following procedures will be invited to participate: thyroidectomy,
      parathyroidectomy, parotidectomy, tympanoplasty, mastoidectomy, endoscopic sinus surgery, and
      septoplasty. All patients will receive Hydrocodone/acetaminophen and Ibuprofen in standard
      dosage and assigned to one of two groups before surgery. Group 1 will use the narcotic
      medication for pain control and ibuprofen for breakthrough pain. Group 2 will use ibuprofen
      for pain control and the narcotic medication for breakthrough. Patients will fill out a data
      sheet for 7 days recording their pain level three times per day as well as pain medication
      usage for each day. This will be collected on their first clinic visit after surgery at which
      point the patient's involvement is completed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2018</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to one of two groups prior to surgery. All patients will be prescribed both Hydrocodone/acetaminophen and Ibuprofen. Group 1 will take the narcotic medication for initial pain control followed by Ibuprofen if pain is not adequately controlled. Group 2 will take Ibuprofen for initial pain control followed by the narcotic medication if pain is not adequately controlled.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Narcotic usage</measure>
    <time_frame>Post operative day 1 to day 7</time_frame>
    <description>Number of narcotic pills needed or used for pain control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient pain level</measure>
    <time_frame>Post operative day 1 to day 7 four times a day designated as Breakfast, Lunch, Dinner, and Night.</time_frame>
    <description>Recorded pain level using Numeric Rating Scale (0-10) with 0 representing no pain and 10 as worse imaginable pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ibuprofen usage</measure>
    <time_frame>Post operative day 1 to day 7</time_frame>
    <description>Number of ibuprofen pills needed or used for pain control</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Outpatient Surgery</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Norco and Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will take Hydrocodone/acetaminophen 5mg/325mg every 6 hours as needed for pain control as first line intervention.
If pain is not controlled after 60 minutes then can take Ibuprofen 600mg every 6 hours as needed for additional pain control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen and Norco</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will take Ibuprofen 600mg every 6 hours as needed for pain control as first line intervention.
If pain is not controlled after 60 minutes then can take Hydrocodone/acetaminophen 5mg/325mg every 6 hours as needed for additional pain control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norco</intervention_name>
    <description>Hydrocodone/Acetaminophen as first line therapy every 6 hours as needed for pain control</description>
    <arm_group_label>Norco and Ibuprofen</arm_group_label>
    <other_name>Hydrocodone/Acetaminophen</other_name>
    <other_name>Narcotic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Ibuprofen as first line therapy every 6 hours as needed for pain control</description>
    <arm_group_label>Ibuprofen and Norco</arm_group_label>
    <other_name>NSAID</other_name>
    <other_name>Motrin</other_name>
    <other_name>Advil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients undergoing one of the following outpatient procedure:

          -  Septoplasty

          -  Unilateral or Bilateral Functional endoscopic sinus surgery

          -  Tympanomastoidectomy

          -  Tympanoplasty

          -  Total or Partial Thyroidectomy

          -  Parathyroidectomy

          -  Parotidectomy.

          -  Age &gt;18 years and &lt; 89 years

        Exclusion Criteria:

          -  Age &lt; 18 years or &gt; 89 years

          -  Post operative hospital admission

          -  Allergy to Hydrocodone

          -  Allergy or contraindication to Ibuprofen or NSAIDs

          -  Pregnancy

          -  Hepatic disease

          -  Chronic kidney disease

          -  Sickle cell anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jared Inman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khanh Nguyen, MD</last_name>
    <phone>909-558-8558</phone>
    <email>khanguyen@llu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Office of Patient Relations</last_name>
    <phone>909-558-4647</phone>
    <email>patientrelations@llu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khanh Nguyen, MD</last_name>
      <phone>909-558-4000</phone>
      <phone_ext>88558</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Surgical Hospital</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khanh Nguyen, MD</last_name>
      <phone>909-558-4000</phone>
      <phone_ext>88558</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1.htm</url>
    <description>CDC report on opioid related deaths</description>
  </link>
  <reference>
    <citation>Sommer M, Geurts JW, Stessel B, Kessels AG, Peters ML, Patijn J, van Kleef M, Kremer B, Marcus MA. Prevalence and predictors of postoperative pain after ear, nose, and throat surgery. Arch Otolaryngol Head Neck Surg. 2009 Feb;135(2):124-30. doi: 10.1001/archoto.2009.3.</citation>
    <PMID>19221238</PMID>
  </reference>
  <reference>
    <citation>Foghsgaard S, Foghsgaard J, Hom√∏e P. Early post-operative morbidity after superficial parotidectomy: a prospective study concerning pain and resumption of normal activity. Clin Otolaryngol. 2007 Feb;32(1):54-7.</citation>
    <PMID>17298314</PMID>
  </reference>
  <reference>
    <citation>Song CM, Ji YB, Bang HS, Kim KR, Kim H, Tae K. Postoperative Pain After Robotic Thyroidectomy by a Gasless Unilateral Axillo-Breast or Axillary Approach. Surg Laparosc Endosc Percutan Tech. 2015 Dec;25(6):478-82. doi: 10.1097/SLE.0000000000000204.</citation>
    <PMID>26422088</PMID>
  </reference>
  <reference>
    <citation>van Dijk JF, Kappen TH, Schuurmans MJ, van Wijck AJ. The Relation Between Patients' NRS Pain Scores and Their Desire for Additional Opioids after Surgery. Pain Pract. 2015 Sep;15(7):604-9. doi: 10.1111/papr.12217. Epub 2014 Apr 16.</citation>
    <PMID>24735082</PMID>
  </reference>
  <reference>
    <citation>van Dijk JF, van Wijck AJ, Kappen TH, Peelen LM, Kalkman CJ, Schuurmans MJ. Postoperative pain assessment based on numeric ratings is not the same for patients and professionals: a cross-sectional study. Int J Nurs Stud. 2012 Jan;49(1):65-71. doi: 10.1016/j.ijnurstu.2011.07.009. Epub 2011 Aug 15.</citation>
    <PMID>21840522</PMID>
  </reference>
  <reference>
    <citation>Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth. 2011 Oct;107(4):619-26. doi: 10.1093/bja/aer195. Epub 2011 Jun 30.</citation>
    <PMID>21724620</PMID>
  </reference>
  <reference>
    <citation>Ossiander EM. Using textual cause-of-death data to study drug poisoning deaths. Am J Epidemiol. 2014 Apr 1;179(7):884-94. doi: 10.1093/aje/kwt333. Epub 2014 Feb 11.</citation>
    <PMID>24521559</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2018</study_first_submitted>
  <study_first_submitted_qc>January 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thyroidectomy</keyword>
  <keyword>Parotidectomy</keyword>
  <keyword>Tympanoplasty</keyword>
  <keyword>Mastoidectomy</keyword>
  <keyword>Septoplasty</keyword>
  <keyword>Sinus Surgery</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Outpatient surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Collected data will be analyzed and published. Meaningful data will be available through published material.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

